Steven P. Coen

Insider

Chief Financial Officer

Trades at: DNA

30D 90D 1Y

Net shares · 90d

-33.8K

0 buy · 33.8K sell

Net value · 90d

-$217.9K

$0 in · $217.9K out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

0 buy · 33.8K sell

Net buy / sell volume (all companies)

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Show open-market only

DNA Sell·S
May 22, 26

Chief Financial Officer

$2.6K

307 sh · $8.33

Own -1%
DNA Exercise·M
May 21, 26

Chief Financial Officer

—

156 sh

Own +5%
DNA Exercise·M
May 21, 26

Chief Financial Officer

—

587 sh

Own +9%
DNA Exercise·M
May 21, 26

Chief Financial Officer

—

156 sh

Own +0%
DNA Exercise·M
May 21, 26

Chief Financial Officer

—

587 sh

Own +1%
DNA Sell·S
Apr 17, 26

Chief Financial Officer

$2.6K

324 sh · $7.95

Own -1%
DNA Exercise·M
Apr 16, 26

Chief Financial Officer

—

156 sh

Own +5%
DNA Exercise·M
Apr 16, 26

Chief Financial Officer

—

587 sh

Own +8%
DNA Exercise·M
Apr 16, 26

Chief Financial Officer

—

156 sh

Own +0%
DNA Exercise·M
Apr 16, 26

Chief Financial Officer

—

587 sh

Own +1%
DNA Sell·S
Apr 13, 26

Chief Financial Officer

$212.8K

33.2K sh · $6.41

Own -40%
DNA Exercise·M
Apr 10, 26

Chief Financial Officer

—

45.6K sh

Own New
DNA Exercise·M
Apr 10, 26

Chief Financial Officer

—

28.4K sh

Own New
DNA Exercise·M
Apr 10, 26

Chief Financial Officer

—

45.6K sh

Own +122%
DNA Exercise·M
Apr 10, 26

Chief Financial Officer

—

28.4K sh

Own +312%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
May 22, 2026	DNA	Chief Financial Officer	Sell S	307	-1%	$8.33	$2.6K
May 21, 2026	DNA	Chief Financial Officer	Exercise M	156	+5%	—	—
May 21, 2026	DNA	Chief Financial Officer	Exercise M	587	+9%	—	—
May 21, 2026	DNA	Chief Financial Officer	Exercise M	156	+0%	—	—
May 21, 2026	DNA	Chief Financial Officer	Exercise M	587	+1%	—	—
Apr 17, 2026	DNA	Chief Financial Officer	Sell S	324	-1%	$7.95	$2.6K
Apr 16, 2026	DNA	Chief Financial Officer	Exercise M	156	+5%	—	—
Apr 16, 2026	DNA	Chief Financial Officer	Exercise M	587	+8%	—	—
Apr 16, 2026	DNA	Chief Financial Officer	Exercise M	156	+0%	—	—
Apr 16, 2026	DNA	Chief Financial Officer	Exercise M	587	+1%	—	—
Apr 13, 2026	DNA	Chief Financial Officer	Sell S	33.2K	-40%	$6.41	$212.8K
Apr 10, 2026	DNA	Chief Financial Officer	Exercise M	45.6K	New	—	—
Apr 10, 2026	DNA	Chief Financial Officer	Exercise M	28.4K	New	—	—
Apr 10, 2026	DNA	Chief Financial Officer	Exercise M	45.6K	+122%	—	—
Apr 10, 2026	DNA	Chief Financial Officer	Exercise M	28.4K	+312%	—	—

About Steven P. Coen

This profile aggregates every SEC Form 4 insider transaction reported by Steven P. Coen across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.